Hemolytic Disease of the Fetus and Newborn
Hematology
2 drugs in development·2 companies·1 clinical trial
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| nipocalimab | GH Research PLC (GHRS) |
Phase 2(1)
| Drug | Company |
|---|---|
| m281 | MOMENTA PHARMACEUTICALS INC (MNTA) |
Compare drugs
Frequently asked questions
How many drugs are in development for Hemolytic Disease of the Fetus and Newborn?
BioSniper tracks 2 drugs in development for Hemolytic Disease of the Fetus and Newborn across 2 companies.
How many clinical trials target Hemolytic Disease of the Fetus and Newborn?
There are 1 clinical trial targeting Hemolytic Disease of the Fetus and Newborn tracked by BioSniper.
Deep-dive into Hemolytic Disease of the Fetus and Newborn
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis